Selected Grants
A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adolescents (age 12 years to < 18 years) with Symptomatic Obstructive Hypertrophic Cardiomyopathy
Clinical TrialPrincipal Investigator · Awarded by Bristoll Myers Squibb · 2024 - 2028ACTION (Advanced Cardiac Therapies Improving Outcomes Network) DMD Database
ResearchCo Investigator · Awarded by Cincinnati Children's Hospital Medical Center · 2024 - 2025External Relationships
- GLG Consultants
- United Therapeutics Corporation
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.